Artra Group Corporation

6029.T
Medical Care Facilities
2026/11/20 20:23 Updated
Market Cap: $11.0M (¥1.7B)
Stock Price: $1.05 (¥167)
Exchange Rate: 1 USD = ¥158.73

Notice Regarding Capital and Business Alliance with REMED JAPAN Co., Ltd. and Acquisition of Its Shares through Subscription to a Third-Party Allotment (Equity-Method Affiliate)

Subscribed to a third-party allotment in REMED JAPAN and made it an equity-method affiliate by acquiring 35% of voting rights; additionally holds a call option to acquire a further 16% in the future. Through this transaction, aims to strengthen domestic sales channels in Japan and expand A-COMS horizontally. Payment is scheduled for early December 2026, with the second stage targeted around 2029.

Importance:
Page Updated: November 17, 2026
IR Disclosure Date: November 17, 2026

Key Figures

  • Acquired percentage of voting rights: 35.0%
  • Number of shares acquired: 156,154 shares
  • Payment timing: early December 2026
  • Call option: Additional 16% of voting rights acquirable
  • Second-stage target: Raise voting rights to 51%

AI要約

Overview and Purpose of the Alliance

We will subscribe to a third-party allotment in REMED JAPAN and acquire 35% of voting rights, making the company an equity-method affiliate. We have also concluded a basic agreement to expand REMED JAPAN's sales within Japan. As an interim measure, REMED JAPAN will dispatch two directors to our company, and a governance structure will be established whereby significant matters require mutual consent.

Future Developments and Schedule

The first-stage payment is scheduled for early December 2026. We hold the right to exercise a call option to additionally acquire shares equivalent to 16% of voting rights, aiming to raise voting rights to 51% as the second stage. The exercise timing will be a specified period after the fiscal year ending December 2028 closing, and valuation will be calculated using an EBITDA multiple method.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Artra Group Corporation

Company overview · Stock price · Financial data · All IR

View company page →